Sema3E Promotes Tumor Progression in Ovarian Endometrioid Cancer
Author Information
Author(s): Tseng Chun-Hsien, Murray Karl D., Jou Mu-Fan, Hsu Su-Ming, Cheng Hwai-Jong, Huang Pei-Hsin
Primary Institution: National Taiwan University
Hypothesis
Sema3E signaling through Plexin-D1 promotes epithelial-to-mesenchymal transition (EMT) and enhances the migratory ability of ovarian endometrioid cancer cells.
Conclusion
Sema3E is highly expressed in high-grade ovarian endometrioid carcinoma and facilitates tumor progression by inducing EMT and enhancing cell migration.
Supporting Evidence
- Sema3E is over-expressed in high-grade ovarian endometrioid carcinoma.
- Sema3E promotes cell migration and EMT through Plexin-D1 signaling.
- Knockdown of Sema3E or its receptors reduces cell motility.
- High Sema3E expression correlates with poor prognosis in ovarian cancer.
Takeaway
This study found that a protein called Sema3E helps cancer cells move and spread in a type of ovarian cancer, making it grow faster.
Methodology
The study involved analyzing tumor samples from patients and conducting in vitro experiments on ovarian endometrioid cancer cell lines to assess Sema3E expression and its effects on cell migration and EMT.
Potential Biases
Potential biases may arise from the selection of tumor samples and the experimental conditions used in cell line studies.
Limitations
The study primarily focused on a specific subtype of ovarian cancer, which may limit the generalizability of the findings to other cancer types.
Participant Demographics
Tumor samples were obtained from 40 patients diagnosed with primary ovarian endometrioid carcinoma, with a mix of ages and tumor grades.
Statistical Information
P-Value
1.98218E-08
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website